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Abstract: A 18-year-old man presented to a local hospital with
muscle weakness, facial edema, and a 6 kg weight gain over 2
months. After a complete work-up, he was diagnosed with pituitary
Cushing syndrome and treated with a bilateral adrenalectomy for
Cushing syndrome and pituitary radiotherapy for Nelson syndrome.
Twenty-five years later, his ectopic source of adrenocorticotropic
hormone was revealed as a pulmonary neuroendocrine tumor, and a
pulmonary resection was performed. Subsequently, a biochemical
and clinical remission including hyperpigmentation was achieved.
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Adrenocorticotropic hormone (ACTH)-dependent Cushingsyndrome, Cushing disease is likely to be diagnosed in
approximately 85% of cases, the remaining patients have
nonpituitary tumors that secrete ACTH and 2% of pulmonary
neuroendocrine tumors are reported to be ectopic ACTH-
producing tumors.1,2
Once the ectopic origins of ACTH other than the
pituitary gland are suspected, careful examination by diagnostic
imaging is necessary. Although inferior petrosal sinus sampling
(IPSS) helps in excluding a pituitary origin, no information
about the source of ectopic ACTH is easily obtained.3 Therefore,
some patients undergo a resection of the pituitary gland or
resection of the hypertrophied adrenal gland during a prolonged
course without a definitive diagnosis.
We report a patient with an ectopic ACTH-producing
pulmonary neuroendocrine tumor, which was not diagnosed
for more than 20 years.
CASE REPORT
A 43-year-old man was referred for a lung mass.
Twenty-five years before this, he presented to a local
hospital with muscle weakness, facial edema, and a 6 kg
weight gain over 2 months. The basal endocrinology and
low-dose dexamethasone suppression test confirmed Cush-
ing syndrome, and after a high-dose dexamethasone sup-
pression test, he failed to suppress cortisol by more than
50%, and initial ACTH was detectable at levels of 104
pg/ml. After a thorough investigation of pituitary CT, chest
and abdomen CT scan, but not IPSS, there was no evidence
of pituitary or ectopic lesion. Although an abdominal CT
scan revealed normal shape and an upper normal size
adrenal gland, considering his young age and being a
single son, a bilateral adrenalectomy was performed for the
treatment of Cushing syndrome. After 2 years, the hyper-
pigmentation on his face and oral cavity was aggravated,
and although there was no abnormality on his pituitary
gland in the sella MRI, he was diagnosed with Nelson
syndrome and received radiotherapy on his pituitary gland.
After that, the patient was under steroid therapy with
antihypertensive drugs, but he still had an elevated ACTH
level and the hyperpigmentation continued. Six months
before the current evaluation, he suffered from a leg
fracture and a preoperative chest radiograph revealed a
3-cm rounded opacity in the right lung. A chest CT
confirmed three nodules with regular margins in the right
middle lobe and an enlarged hilar node. A positron emis-
sion tomography scan showed mild hypermetabolism in
the mass and node (Figure 1). A percutaneous needle
biopsy revealed a neuroendocrine tumor. The preoperative
level of ACTH was 9280 pg/ml and it might have resulted
from these lesions. The patient underwent a right middle
lobectomy and a complete mediastinal, hilar lymph node
dissection. On permanent pathologic examination, there
were three separate nodules at the same lobe and four
metastatic nodes at subcarinal, hilar, and peribronchial
area; therefore, pathologic stage is IIIB (T4N2M0). His-
tology showed neuroendocrine carcinoma with positive
immunostaining for ACTH (Figure 2). Subsequently, a
biochemical findings (ACTH level is 95 pg/ml 2 years after
operation) normalized, clinical remission including hyper-
pigmentation disappeared, and 24 months after operation,
the patient is cured (Figure 3).
COMMENT
When faced with ACTH-dependent Cushing syn-
drome, it is very difficult to differentiate Cushing disease
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from ectopic origin. In a brain MRI, a lack of demonstrable
tumor is often seen in cases of Cushing disease and even in
an IPSS, a clear central gradient is almost a pathogno-
monic finding in Cushing disease but a negative central
gradient might be seen in a minority of patients with
Cushing disease.1 Therefore, a standard technique in lo-
calizing ACTH-producing tumors is not available so far. In
the case described, both a pituitary CT scan and sella MRI
failed to demonstrate a pituitary tumor and there was no
evidence of an ectopic source of ACTH, it was felt that this
was probably a case of pituitary-dependent Cushing syn-
drome at that time.
The mean interval between the onset of Cushing
syndrome and the definite diagnosis of an ectopic ACTH-
producing tumor was reported to be 24 months, and that
between the onset and surgery was 52 months, but an
interval of more than 20 years is very rare.4,5 This long
interval is partly because the tumor diameter is less than
1.0 cm in many patients, so that a chest radiograph shows no
abnormalities and the tumor grows very slowly.2 During a
prolonged course of disease, some patients undergo a resection
of the pituitary gland or resection of the hypertrophied adrenal
glands. To detect an ectopic source, some investigator suggested
that dedicated imaging with chest, abdominal, and pelvic CT
scans, plus possibly a MRI of the mediastinum and pelvis are
prudent.1 Scintigraphy with either 123I-meta-iodobenzylguani-
dine or 111In-octreotide has varying reported use in diagnosing
ectopic source. A positron emission tomography with 18fluoro-
FIGURE 1. A, chest radiograph
showing a 3-cm sized round opacity
in the right lung; B, positron emission
tomography with 18fluorodeoxyglu-
cose demonstrating hypermetabolism
(mSUV  2.6) on right middle lobe;
C, chest CT imaging of the chest
showing nodules with regular margins
in the right middle lobe (left: the big-
gest nodule, right: second nodule,
third nodule was not shown).
FIGURE 2. The specimen was immunohistochemical
stained by ACTH (400).
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deoxyglucose is an interesting technique that might prove useful,
at least for detecting fast-growing tumors, although 11C-5-hy-
droxytryptophan, if available, might be more promising.1,3,6
In this case, when the hyperpigmentation was aggra-
vated, it was unclear if Nelson syndrome had developed
because there was no microadenoma in a sella MRI, and after
radiotherapy on the pituitary gland, the hyperpigmentation
continued. Therefore, the hyperpigmentation might be aggra-
vated with an increase of ACTH from the ectopic source.
Survival of patients with ectopic ACTH syndrome de-
pends on the source of the primary tumor; those with a small-cell
lung carcinoma fare poorly, but the more indolent tumors,
especially the pulmonary neuroendocrine, show prolonged sur-
vival.7 In the case of a pulmonary neuroendocrine tumor, despite
long delays in surgical therapy, an anatomic resection with a
complete mediastinal lymphadenectomy decreases a local recur-
rence and results in a favorable prognosis.8
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FIGURE 3. Preoperative (A) and
postoperative (B) skin pigmentation:
face and hands. A, preoperative im-
ages; B, postoperative images (2 years
after operation).
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